| Name | Viskase Holdings, Inc. |
|---|---|
| CIK | 0000727510 |
| Tickers | VISK |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 222372868 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (630) 874-0700 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
1517 filing rows loaded from submissions recent; extra archives: CIK0000727510-submissions-001.json (517 filings, 1995-03-03 to 2004-11-15).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-03 | 10-Q | 10-Q | 0001104659-26-121529 | 000-12957 | 261513888 | 34 | 12763906 | 1 | 1 | |
| 2026-08-03 | 10-Q | 10-Q | 0001104659-26-089804 | 000-12957 | 261233083 | 34 | 12340251 | 1 | 1 | |
| 2026-05-05 | 8-A12G | 8-A12G | 0001104659-26-055637 | 000-12957 | 26943302 | 34 | 44845 | |||
| 2026-05-05 | 8-K | FORM 8-K | 1.01,3.03,5.03,7.01,9.01 | 0001104659-26-055632 | 000-12957 | 26943185 | 34 | 756465 | 1 | 1 |
| 2026-05-04 | 10-Q | 10-Q | 0001104659-26-054911 | 000-12957 | 26937845 | 34 | 9385093 | 1 | 1 | |
| 2026-05-01 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-053545 | 17698 | ||||||
| 2026-05-01 | 8-K/A | FORM 8-K/A | 9.01 | 0001104659-26-053523 | 000-12957 | 26929095 | 34 | 1803431 | 1 | 1 |
| 2026-05-01 | 8-K | FORM 8-K | 5.02 | 0001104659-26-053522 | 000-12957 | 26929091 | 34 | 192047 | 1 | 1 |
| 2026-04-29 | 10-K/A | 10-K/A | 0001104659-26-051643 | 000-12957 | 26917541 | 34 | 708604 | 1 | 1 | |
| 2026-04-21 | 8-K | FORM 8-K | 1.01,2.03,9.01 | 0001104659-26-046064 | 000-12957 | 26880047 | 34 | 1869098 | 1 | 1 |
| 2026-04-16 | 8-K | FORM 8-K | 4.01,9.01 | 0001104659-26-044420 | 000-12957 | 26868056 | 34 | 203372 | 1 | 1 |
| 2026-04-15 | 8-K | FORM 8-K | 5.02 | 0001104659-26-043811 | 000-12957 | 26864358 | 34 | 186207 | 1 | 1 |
| 2026-03-27 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000274 | 14700 | ||||||
| 2026-03-27 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-129970 | 005-35587 | 26809553 | 34 | 12805 | |||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035420 | 21225 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035418 | 3404 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035417 | 19732 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035416 | 3396 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035415 | 3402 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035414 | 19689 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035413 | 20530 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035411 | 19144 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035410 | 18866 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035409 | 19726 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035408 | 20156 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035407 | 3424 | ||||||
| 2026-03-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-035406 | 3507 | ||||||
| 2026-03-26 | 8-K | FORM 8-K | 2.01,3.02,5.01,5.02,5.03,7.01,9.01 | 0001104659-26-035301 | 000-12957 | 26799558 | 34 | 252273 | 1 | 1 |
| 2026-03-25 | 425 | 425 | 0001104659-26-034194 | 000-12957 | 26788501 | 34 | 22547 | |||
| 2026-03-25 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-034187 | 000-12957 | 26788495 | 34 | 183932 | 1 | 1 |
| 2026-03-25 | SC TO-I/A | SC TO-I/A | 0001104659-26-034177 | 005-35587 | 26788486 | 34 | 26692 | |||
| 2026-03-24 | SC TO-I/A | SC TO-I/A | 0001104659-26-033627 | 005-35587 | 26784280 | 34 | 20418 | |||
| 2026-03-24 | 8-A12G/A | 8-A12G/A | 0001104659-26-033626 | 000-12957 | 26784277 | 34 | 39768 | |||
| 2026-03-24 | 425 | 425 | 0001104659-26-033625 | 000-12957 | 26784275 | 34 | 85863 | |||
| 2026-03-24 | 8-K | FORM 8-K | 1.01,3.03,5.03,7.01,9.01 | 0001104659-26-033624 | 000-12957 | 26784271 | 34 | 269022 | 1 | 1 |
| 2026-03-19 | 425 | 425 | 0001104659-26-032098 | 000-12957 | 26774479 | 34 | 29529 | |||
| 2026-03-19 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-032092 | 000-12957 | 26774439 | 34 | 193969 | 1 | 1 |
| 2026-03-19 | SC TO-I/A | SC TO-I/A | 0001104659-26-032068 | 005-35587 | 26774294 | 34 | 41393 | |||
| 2026-03-18 | 8-A12G/A | 8-A12G/A | 0001104659-26-029974 | 000-12957 | 26765834 | 34 | 35445 | |||
| 2026-03-18 | 425 | 425 | 0001104659-26-029960 | 000-12957 | 26765802 | 34 | 44841 | |||
| 2026-03-18 | 8-K | FORM 8-K | 1.01,3.03,9.01 | 0001104659-26-029952 | 000-12957 | 26765787 | 34 | 211881 | 1 | 1 |
| 2026-03-16 | 425 | 425 | 0001104659-26-028459 | 000-12957 | 26756780 | 34 | 33398 | |||
| 2026-03-16 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-028449 | 000-12957 | 26756667 | 34 | 196188 | 1 | 1 |
| 2026-03-16 | SC TO-I/A | SC TO-I/A | 0001104659-26-028435 | 005-35587 | 26756479 | 34 | 41644 | |||
| 2026-03-11 | 8-A12G/A | 8-A12G/A | 0001104659-26-026175 | 000-12957 | 26741654 | 34 | 35515 | |||
| 2026-03-11 | 425 | 425 | 0001104659-26-026171 | 000-12957 | 26741647 | 34 | 56756 | |||
| 2026-03-11 | 8-K | FORM 8-K | 1.01,3.03,7.01,9.01 | 0001104659-26-026169 | 000-12957 | 26741641 | 34 | 228454 | 1 | 1 |
| 2026-03-11 | SC TO-I/A | SC TO-I/A | 0001104659-26-026167 | 005-35587 | 26741632 | 34 | 41638 | |||
| 2026-03-09 | 425 | 425 | 0001104659-26-025226 | 000-12957 | 26735092 | 34 | 29321 | |||
| 2026-03-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-025217 | 000-12957 | 26735025 | 34 | 193740 | 1 | 1 |
| 2026-03-09 | SC TO-I/A | SC TO-I/A | 0001104659-26-025204 | 005-35587 | 26734913 | 34 | 40807 | |||
| 2026-03-03 | 424B3 | 424B3 | 0001104659-26-022903 | 333-293019 | 26715037 | 33 | 1057287 | |||
| 2026-03-03 | SC TO-I/A | SC TO-I/A | 0001104659-26-022899 | 005-35587 | 26714969 | 34 | 1059271 | |||
| 2026-03-02 | 10-K | 10-K | 0001104659-26-022313 | 000-12957 | 26708856 | 34 | 4368430 | 1 | 1 | |
| 2026-02-27 | 8-A12G/A | 8-A12G/A | 0001104659-26-021059 | 000-12957 | 26692913 | 34 | 35916 | |||
| 2026-02-27 | 425 | 425 | 0001104659-26-021053 | 000-12957 | 26692884 | 34 | 57637 | |||
| 2026-02-27 | 8-K | FORM 8-K | 1.01,3.03,7.01,9.01 | 0001104659-26-021051 | 000-12957 | 26692872 | 34 | 228661 | 1 | 1 |
| 2026-02-27 | SC TO-I/A | SC TO-I/A | 0001104659-26-021045 | 005-35587 | 26692829 | 34 | 39415 | |||
| 2026-02-26 | SC 14F1 | SC 14F1 | 0001104659-26-020478 | 005-35587 | 26687795 | 34 | 216675 | |||
| 2026-02-11 | SC TO-I/A | SC TO-I/A | 0001104659-26-013530 | 005-35587 | 26622108 | 34 | 19749 | |||
| 2026-02-11 | 425 | 425 | 0001104659-26-013514 | 000-12957 | 26622033 | 34 | 36192 | |||
| 2026-02-11 | 8-K | FORM 8-K | 5.07,9.01 | 0001104659-26-013506 | 000-12957 | 26621996 | 34 | 198755 | 1 | 1 |
| 2026-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000433 | 333-293019 | 26585545 | 33 | 2059 | ||
| 2026-01-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-032170 | 005-35587 | 26584933 | 34 | 11711 | |||
| 2026-01-30 | SC TO-I | SC TO-I | 0001104659-26-008693 | 005-35587 | 26584167 | 34 | 212808 | 1 | 1 | |
| 2026-01-30 | 424B3 | 424B3 | 0001104659-26-008680 | 333-293019 | 26584017 | 33 | 10083232 | |||
| 2026-01-30 | S-4/A | S-4/A | 0001104659-26-008573 | 333-293019 | 26582879 | 33 | 374401 | |||
| 2026-01-30 | 8-A12G/A | 8-A12G/A | 0001104659-26-008334 | 000-12957 | 26580660 | 34 | 30994 | |||
| 2026-01-30 | 8-K | FORM 8-K | 1.01,3.03,9.01 | 0001104659-26-008322 | 000-12957 | 26580609 | 34 | 208893 | 1 | 1 |
| 2026-01-28 | CORRESP | filename1.htm | 0001104659-26-007497 | 8122 | ||||||
| 2026-01-28 | S-4 | S-4 | 0001104659-26-007463 | 333-293019 | 26573375 | 33 | 26043397 | 1 | 1 | |
| 2025-12-29 | UPLOAD | filename1.pdf | 0000000000-25-011845 | 377-08849 | 40814 | |||||
| 2025-12-23 | 8-A12G/A | 8-A12G/A | 0001104659-25-124262 | 000-12957 | 251601390 | 34 | 30144 | |||
| 2025-12-23 | 8-K | FORM 8-K | 1.01,3.03,9.01 | 0001104659-25-124254 | 000-12957 | 251601317 | 34 | 209134 | 1 | 1 |
| 2025-12-19 | DRS | filename1.htm | 0001104659-25-123300 | 377-08849 | 251588625 | 33 | 14441479 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001104659-25-110410 | 000-12957 | 251473141 | 34 | 3376903 | 1 | 1 | |
| 2025-10-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-249981 | 005-35587 | 251416357 | 34 | 16253 | |||
| 2025-10-24 | 425 | 425 | 0001104659-25-102131 | 000-12957 | 251416165 | 34 | 156917 | |||
| 2025-10-24 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001104659-25-102127 | 000-12957 | 251416129 | 34 | 348601 | 1 | 1 |
| 2025-09-30 | 8-A12G/A | 8-A12G/A | 0001104659-25-095083 | 000-12957 | 251361173 | 34 | 29935 | |||
| 2025-09-30 | 8-K | FORM 8-K | 1.01,3.03,9.01 | 0001104659-25-095078 | 000-12957 | 251361149 | 34 | 210488 | 1 | 1 |
| 2025-08-14 | 8-A12G/A | 8-A12G/A | 0001104659-25-078663 | 000-12957 | 251219947 | 34 | 30733 | |||
| 2025-08-14 | 10-Q | 10-Q | 0001410578-25-001810 | 000-12957 | 251218835 | 34 | 3222557 | 1 | 1 | |
| 2025-06-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-061414 | 005-35587 | 251063030 | 34 | 19034 | |||
| 2025-06-23 | 425 | 425 | 0001104659-25-061313 | 000-12957 | 251062867 | 34 | 903142 | 1 | 1 | |
| 2025-06-23 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001104659-25-061311 | 000-12957 | 251062863 | 34 | 1242136 | 1 | 1 |
| 2025-05-09 | 10-Q | 10-Q | 0001410578-25-001164 | 000-12957 | 25930355 | 34 | 2689274 | 1 | 1 | |
| 2025-04-28 | 10-K/A | 10-K/A | 0001104659-25-040183 | 000-12957 | 25880263 | 34 | 728464 | 1 | 1 | |
| 2025-04-01 | 8-A12G/A | 8-A12G/A | 0001104659-25-030601 | 000-12957 | 25800341 | 34 | 29151 | |||
| 2025-04-01 | 8-K | FORM 8-K | 1.01,3.03,9.01 | 0001104659-25-030585 | 000-12957 | 25800227 | 34 | 213997 | 1 | 1 |
| 2025-02-21 | 10-K | 10-K | 0001410578-25-000177 | 000-12957 | 25651749 | 34 | 3910565 | 1 | 1 | |
| 2025-01-10 | 3 | OWNERSHIP DOCUMENT | 0001104659-25-002595 | 3318 | ||||||
| 2025-01-10 | 8-K | FORM 8-K | 5.02,8.01 | 0001104659-25-002591 | 000-12957 | 25523775 | 34 | 197977 | 1 | 1 |
| 2024-12-27 | 8-K | FORM 8-K | 8.01 | 0001104659-24-132163 | 000-12957 | 241586039 | 34 | 188261 | 1 | 1 |
| 2024-12-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-24-130184 | 005-35587 | 241563758 | 34 | 21687 | |||
| 2024-11-05 | 10-Q | 10-Q | 0001410578-24-001747 | 000-12957 | 241427445 | 34 | 3339262 | 1 | 1 | |
| 2024-10-01 | 8-K | FORM 8-K | 5.07 | 0001104659-24-104951 | 000-12957 | 241343730 | 34 | 205366 | 1 | 1 |
| 2024-08-19 | SC 13D/A | SC 13D/A | 0001104659-24-090923 | 005-35587 | 241221999 | 34 | 22445 | |||
| 2024-08-08 | ARS | ARS | 0001104659-24-087312 | 000-12957 | 241189081 | 34 | 9038959 | |||
| 2024-08-08 | DEFA14A | DEFA14A | 0001104659-24-087309 | 000-12957 | 241189033 | 34 | 957200 | |||
| 2024-08-08 | DEF 14A | DEF 14A | 0001104659-24-087308 | 000-12957 | 241189012 | 34 | 1239494 | |||
| 2024-08-08 | 10-Q | 10-Q | 0001410578-24-001220 | 000-12957 | 241188195 | 34 | 3242505 | 1 | 1 | |
| 2024-07-29 | PRE 14A | PRE 14A | 0001104659-24-083568 | 000-12957 | 241152979 | 34 | 3091206 | |||
| 2024-07-11 | 8-K/A | FORM 8-K/A | 5.08 | 0001104659-24-079255 | 000-12957 | 241112590 | 34 | 190535 | 1 | 1 |
| 2024-07-02 | 8-K | FORM 8-K | 5.08 | 0001104659-24-077371 | 000-12957 | 241096040 | 34 | 189125 | 1 | 1 |
| 2024-06-14 | 8-K | FORM 8-K | 8.01 | 0001104659-24-071747 | 000-12957 | 241044704 | 34 | 188037 | 1 | 1 |
| 2024-05-22 | 8-A12G/A | 8-A12G/A | 0001104659-24-064260 | 000-12957 | 24973349 | 34 | 24399 | |||
| 2024-05-22 | 8-K | FORM 8-K | 1.01,3.03,9.01 | 0001104659-24-064247 | 000-12957 | 24973239 | 34 | 214726 | 1 | 1 |
| 2024-05-10 | 10-Q | 10-Q | 0001410578-24-000735 | 000-12957 | 24934884 | 34 | 2939922 | 1 | 1 | |
| 2024-04-26 | 10-K/A | FORM 10-K/A | 0001104659-24-052919 | 000-12957 | 24883613 | 34 | 393785 | 1 | 1 | |
| 2024-03-20 | 10-K | 10-K | 0001410578-24-000245 | 000-12957 | 24767818 | 34 | 3798107 | 1 | 1 | |
| 2024-01-05 | 8-K | FORM 8-K | 8.01 | 0001104659-24-001789 | 000-12957 | 24516251 | 34 | 187512 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0001410578-23-002306 | 000-12957 | 231393108 | 34 | 3149234 | 1 | 1 | |
| 2023-08-07 | 10-Q | 10-Q | 0001410578-23-001577 | 000-12957 | 231147622 | 34 | 3080826 | 1 | 1 | |
| 2023-06-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-072222 | 6285 | ||||||
| 2023-06-14 | 8-K | FORM 8-K | 5.07 | 0001104659-23-071184 | 000-12957 | 231014140 | 34 | 200711 | 1 | 1 |
| 2023-05-05 | 10-Q | 10-Q | 0001410578-23-000888 | 000-12957 | 23893798 | 34 | 2794397 | 1 | 1 | |
| 2023-04-20 | ARS | ARS | 0001104659-23-047872 | 000-12957 | 23833928 | 34 | 319909 | |||
| 2023-04-20 | DEFA14A | DEFA14A | 0001104659-23-047868 | 000-12957 | 23833909 | 34 | 622534 | |||
| 2023-04-20 | DEF 14A | DEF 14A | 0001104659-23-047865 | 000-12957 | 23833897 | 34 | 2634436 | |||
| 2023-02-16 | 10-K | 10-K | 0001410578-23-000136 | 000-12957 | 23638597 | 34 | 3754118 | 1 | 1 | |
| 2023-01-06 | 8-K | FORM 8-K | 8.01 | 0001104659-23-001851 | 000-12957 | 23515087 | 34 | 188774 | 1 | 1 |
| 2022-11-09 | 10-Q | 10-Q | 0001410578-22-003068 | 000-12957 | 221372625 | 34 | 2971126 | 1 | 1 | |
| 2022-08-04 | 10-Q | 10-Q | 0001410578-22-002040 | 000-12957 | 221136511 | 34 | 2906091 | 1 | 1 | |
| 2022-06-21 | 3 | FORM 3 | 0001104659-22-072978 | 3305 | ||||||
| 2022-06-15 | 8-K | FORM 8-K | 5.07 | 0001104659-22-071455 | 000-12957 | 221017951 | 34 | 203434 | 1 | 1 |
| 2022-04-26 | 10-Q | 10-Q | 0001410578-22-001018 | 000-12957 | 22854320 | 34 | 2673912 | 1 | 1 | |
| 2022-04-22 | DEFA14A | DEFA14A | 0001104659-22-048988 | 000-12957 | 22845812 | 34 | 574432 | |||
| 2022-04-22 | DEF 14A | DEF 14A | 0001104659-22-048979 | 000-12957 | 22845739 | 34 | 2177694 | |||
| 2022-02-25 | 10-K | 10-K | 0001410578-22-000226 | 000-12957 | 22680692 | 34 | 4001729 | 1 | 1 | |
| 2021-11-05 | 10-Q | FORM 10-Q | 0001410578-21-000030 | 000-12957 | 211384512 | 34 | 2836567 | 1 | 1 | |
| 2021-08-17 | 4 | OWNERSHIP DOCUMENT | 0000921895-21-002138 | 16486 | ||||||
| 2021-08-05 | 10-Q | FORM 10-Q | 0001104659-21-100764 | 000-12957 | 211148413 | 34 | 2557432 | 1 | 1 | |
| 2021-06-08 | 8-A12G/A | 8-A12G/A | 0001104659-21-078224 | 000-12957 | 211003375 | 34 | 21295 | |||
| 2021-06-08 | 8-K | FORM 8-K | 1.01,3.03,5.07,9.01 | 0001104659-21-078218 | 001-36435 | 211002196 | 34 | 58756 | ||
| 2021-05-04 | 10-Q | FORM 10-Q | 0001104659-21-060966 | 001-36435 | 21888435 | 34 | 1703126 | 1 | ||
| 2021-04-14 | DEFA14A | DEFA14A | 0001104659-21-050227 | 001-36435 | 21825938 | 34 | 426270 | |||
| 2021-04-14 | DEF 14A | DEF 14A | 0001104659-21-050212 | 001-36435 | 21825868 | 34 | 3511114 | |||
| 2021-04-02 | PRE 14A | PRE 14A | 0001104659-21-046091 | 001-36435 | 21802148 | 34 | 653836 | |||
| 2021-02-23 | 10-K | FORM 10-K | 0001104659-21-026712 | 001-36435 | 21665380 | 34 | 3351888 | 1 | ||
| 2021-01-04 | 8-K | FORM 8-K | 5.02,9.01 | 0001104659-21-000308 | 001-36435 | 21501878 | 34 | 50591 | ||
| 2020-12-21 | 8-K | FORM 8-K | 5.07 | 0001104659-20-138068 | 001-36435 | 201404528 | 34 | 25299 | ||
| 2020-11-24 | 424B3 | 424B3 | 0001104659-20-129013 | 333-250031 | 201344333 | 33 | 197029 | |||
| 2020-11-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-11-23 16:00:00 | 9999999995-20-003279 | 333-250031 | 201339789 | 33 | 2018 | ||
| 2020-11-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-126957 | 6769 | ||||||
| 2020-11-18 | CORRESP | filename1.htm | 0001104659-20-126857 | 12029 | ||||||
| 2020-11-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-126458 | 5311 | ||||||
| 2020-11-17 | UPLOAD | filename1.pdf | 0000000000-20-011021 | 40407 | ||||||
| 2020-11-12 | S-1 | FORM S-1 | 0001104659-20-124408 | 333-250031 | 201306839 | 33 | 370613 | |||
| 2020-11-09 | 10-Q | FORM 10-Q | 0001104659-20-123067 | 001-36435 | 201297895 | 34 | 2922048 | 1 | ||
| 2020-11-03 | DEFA14A | DEFA14A | 0001104659-20-120990 | 001-36435 | 201284058 | 34 | 1593631 | |||
| 2020-11-03 | DEF 14A | DEF 14A | 0001104659-20-120989 | 001-36435 | 201284046 | 34 | 1100414 | |||
| 2020-10-14 | 4 | FORM 4 | 0001567619-20-017815 | 13259 | ||||||
| 2020-10-14 | SC 13D/A | enzonsc13da10142020.htm | 0000928464-20-000065 | 005-35587 | 201239506 | 34 | 75945 | |||
| 2020-10-14 | 8-K | FORM 8-K | 3.02,8.01 | 0001104659-20-114940 | 001-36435 | 201239468 | 34 | 22489 | ||
| 2020-09-23 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001104659-20-107817 | 001-36435 | 201192250 | 34 | 90594 | ||
| 2020-09-23 | 424B3 | 424B3 | 0001104659-20-107616 | 333-248528 | 201191049 | 33 | 534970 | |||
| 2020-09-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-09-21 16:00:00 | 9999999995-20-002518 | 333-248528 | 201187788 | 33 | 2018 | ||
| 2020-09-17 | SC 13D/A | AMENDMENT NO. 2 TO THE SCHEDULE 13D | 0000921895-20-002429 | 005-35587 | 201181337 | 34 | 232718 | |||
| 2020-09-17 | CORRESP | filename1.htm | 0001104659-20-106072 | 12694 | ||||||
| 2020-09-15 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-20-105243 | 001-36435 | 201176215 | 34 | 36661 | ||
| 2020-09-15 | S-1/A | S-1/A | 0001104659-20-105076 | 333-248528 | 201174855 | 33 | 1093523 | |||
| 2020-09-08 | UPLOAD | filename1.pdf | 0000000000-20-008418 | 40574 | ||||||
| 2020-09-02 | 8-K | FORM 8-K | 5.08,8.01,9.01 | 0001104659-20-101872 | 001-36435 | 201157164 | 34 | 42318 | ||
| 2020-09-01 | SC 13D/A | enzonsc13da09012020.htm | 0000928464-20-000053 | 005-35587 | 201154959 | 34 | 14834 | |||
| 2020-09-01 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-20-101397 | 001-36435 | 201154618 | 34 | 133079 | ||
| 2020-09-01 | S-1 | FORM S-1 | 0001104659-20-101387 | 333-248528 | 201154582 | 33 | 738786 | |||
| 2020-08-31 | 8-K | FORM 8-K | 8.01 | 0001104659-20-100821 | 001-36435 | 201152019 | 34 | 23366 | ||
| 2020-08-26 | 4 | OWNERSHIP DOCUMENT | 0000921895-20-002331 | 23511 | ||||||
| 2020-08-18 | 3 | FORM 3 | 0001104659-20-096633 | 14032 | ||||||
| 2020-08-14 | 8-K | FORM 8-K | 1.01,3.03,5.03,8.01,9.01 | 0001104659-20-095642 | 001-36435 | 201106504 | 34 | 523845 | ||
| 2020-08-14 | 8-A12G | 8-A12G | 0001104659-20-095639 | 000-12957 | 201106479 | 34 | 480116 | |||
| 2020-08-14 | 3 | FORM 3 | 0001104659-20-095224 | 13169 | ||||||
| 2020-08-07 | SC 13D/A | enzonsc13da08072020.htm | 0000928464-20-000032 | 005-35587 | 201086835 | 34 | 10910 | |||
| 2020-08-07 | 8-K | FORM 8-K | 5.02 | 0001104659-20-092029 | 001-36435 | 201085616 | 34 | 23035 | ||
| 2020-08-06 | 4 | OWNERSHIP DOCUMENT | 0000921895-20-002115 | 21793 | ||||||
| 2020-08-06 | 3 | OWNERSHIP DOCUMENT | 0000921895-20-002114 | 20931 | ||||||
| 2020-08-05 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-20-002102 | 005-35587 | 201078383 | 34 | 278563 | |||
| 2020-07-29 | 10-Q | FORM 10-Q | 0001104659-20-087796 | 001-36435 | 201057384 | 34 | 1568925 | 1 | ||
| 2020-04-30 | 10-Q | FORM 10-Q | 0001104659-20-054427 | 001-36435 | 20835688 | 34 | 1419822 | 1 | ||
| 2020-04-24 | 10-K/A | FORM 10-K/A | 0001104659-20-050989 | 001-36435 | 20815013 | 34 | 212507 | |||
| 2020-04-16 | SC 13D | THE SCHEDULE 13D | 0000921895-20-001119 | 005-35587 | 20796985 | 34 | 167574 | |||
| 2020-03-31 | 4/A | OWNERSHIP DOCUMENT | 0000921895-20-000958 | 19033 | ||||||
| 2020-03-31 | 3 | OWNERSHIP DOCUMENT | 0000921895-20-000957 | 4865 | ||||||
| 2020-03-27 | 4 | xslF345X03/e619511_4-enzn.xml | 0001193805-20-000418 | 16895 | ||||||
| 2020-03-27 | SC 13G/A | AMENDMENT NO. 3 TO THE SCHEDULE 13G | 0000921895-20-000931 | 005-35587 | 20753064 | 34 | 145294 | |||
| 2020-02-19 | 10-K | FORM 10-K | 0001104659-20-022802 | 001-36435 | 20629673 | 34 | 2716545 | 1 | ||
| 2020-01-22 | SC 13G/A | SC 13G/A | 0001104659-20-005975 | 005-35587 | 20539528 | 34 | 105024 | |||
| 2020-01-16 | SC 13G/A | SC 13G/A | 0001062993-20-000184 | 005-35587 | 20529446 | 34 | 30587 | |||
| 2019-11-06 | 10-Q | FORM 10-Q | 0001104659-19-060500 | 001-36435 | 191196313 | 34 | 1604763 | 1 | ||
| 2019-08-22 | 8-K | 8-K | 5.07,8.01 | 0001104659-19-046989 | 001-36435 | 191046698 | 34 | 47001 | ||
| 2019-08-07 | 10-Q | FORM 10-Q | 0001144204-19-038191 | 001-36435 | 191005470 | 34 | 1567916 | 1 | ||
| 2019-07-12 | DEFA14A | DEFA14A | 0001140361-19-012844 | 001-36435 | 19952077 | 34 | 413443 | |||
| 2019-07-12 | DEF 14A | DEF 14A | 0001140361-19-012843 | 001-36435 | 19952076 | 34 | 683692 | |||
| 2019-05-08 | 10-Q | FORM 10-Q | 0001144204-19-024510 | 001-36435 | 19806799 | 34 | 1518855 | 1 | ||
| 2019-04-25 | 10-K/A | 10-K/A | 0001144204-19-021264 | 001-36435 | 19767634 | 34 | 187088 | |||
| 2019-02-21 | 10-K | FORM 10-K | 0001144204-19-009301 | 001-36435 | 19621902 | 34 | 3664184 | 1 | ||
| 2019-02-14 | 4 | OWNERSHIP DOCUMENT | 0000921895-19-000500 | 18484 | ||||||
| 2019-02-14 | SC 13G/A | AMENDMENT NO. 2 TO THE SCHEDULE 13G | 0000921895-19-000426 | 005-35587 | 19604076 | 34 | 111383 | |||
| 2019-02-01 | 8-K | FORM 8-K | 8.01 | 0001144204-19-004157 | 001-36435 | 19557123 | 34 | 18343 | ||
| 2019-01-31 | SC 13G/A | SC 13G/A | 0001144204-19-004131 | 005-35587 | 19556664 | 34 | 91862 | |||
| 2019-01-09 | 4 | OWNERSHIP DOCUMENT | 0000921895-19-000048 | 41629 | ||||||
| 2019-01-09 | 4 | OWNERSHIP DOCUMENT | 0000921895-19-000047 | 55421 | ||||||
| 2019-01-03 | SC 13G/A | SC 13G/A | 0001062993-19-000013 | 005-35587 | 19504271 | 34 | 26853 | |||
| 2018-11-07 | 10-Q | 10-Q | 0001144204-18-057974 | 001-36435 | 181166505 | 34 | 1835843 | 1 | ||
| 2018-08-13 | 8-K | FORM 8-K | 5.07 | 0001144204-18-043721 | 001-36435 | 181010260 | 34 | 25257 | ||
| 2018-08-10 | 10-Q | FORM 10-Q | 0001144204-18-043614 | 001-36435 | 181009038 | 34 | 1981896 | 1 | ||
| 2018-06-29 | DEFA14A | DEFA14A | 0001144204-18-036477 | 001-36435 | 18927277 | 34 | 365248 | |||
| 2018-06-29 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001144204-18-036475 | 001-36435 | 18927276 | 34 | 505075 | |||
| 2018-05-10 | 10-Q | FORM 10-Q | 0001144204-18-027186 | 001-36435 | 18823848 | 34 | 1403678 | 1 | ||
| 2018-04-25 | 10-K/A | 10-K/A | 0001144204-18-022403 | 001-36435 | 18774746 | 34 | 218506 | |||
| 2018-04-13 | 3 | OWNERSHIP DOCUMENT | 0000921895-18-001310 | 10382 | ||||||
| 2018-04-13 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-18-001302 | 005-35587 | 18754120 | 34 | 116123 | |||
| 2018-03-21 | 10-K | 10-K | 0001144204-18-016199 | 001-36435 | 18705091 | 34 | 2991534 | 1 | ||
| 2018-02-13 | 15-12G | 15-12G | 0001144204-18-007983 | 000-12957 | 18603970 | 34 | 12219 | |||
| 2018-02-09 | SC 13G | SCHEDULE 13G | 0001144204-18-007007 | 005-35587 | 18592887 | 34 | 88983 | |||
| 2018-01-22 | SC 13G | SC 13G | 0001062993-18-000271 | 005-35587 | 18540519 | 34 | 26795 | |||
| 2017-11-09 | 10-Q | FORM 10-Q | 0001144204-17-057832 | 001-36435 | 171191888 | 34 | 1435345 | 1 | ||
| 2017-08-10 | 8-K | FORM 8-K | 8.01 | 0001144204-17-042087 | 001-36435 | 171021981 | 34 | 16128 | ||
| 2017-08-10 | 10-Q | FORM 10-Q | 0001144204-17-042058 | 001-36435 | 171021654 | 34 | 1419195 | 1 | ||
| 2017-06-30 | 8-K | FORM 8-K | 5.07,8.01 | 0001144204-17-035053 | 001-36435 | 17940284 | 34 | 35475 | ||
| 2017-05-24 | SC 13G | THE SCHEDULE 13G | 0000921895-17-001629 | 005-35587 | 17867110 | 34 | 58873 | |||
| 2017-05-12 | DEFA14A | DEFA14A | 0001144204-17-026614 | 001-36435 | 17836385 | 34 | 934348 | |||
| 2017-05-12 | DEF 14A | DEF 14A | 0001144204-17-026613 | 001-36435 | 17836381 | 34 | 924916 | |||
| 2017-05-11 | 10-Q | FORM 10-Q | 0001144204-17-026492 | 001-36435 | 17835005 | 34 | 1386101 | 1 | ||
| 2017-04-28 | 10-K/A | FORM 10-K/A | 0001144204-17-022820 | 001-36435 | 17791535 | 34 | 179700 | |||
| 2017-03-24 | 10-K | 10-K | 0001144204-17-016511 | 001-36435 | 17712877 | 34 | 3261061 | 1 | ||
| 2017-02-14 | SC 13G/A | 13G/A | 0001037389-17-000072 | 005-35587 | 17603240 | 34 | 13533 | |||
| 2016-12-08 | SC 13D/A | enznsch13damd10120816.htm | 0000928464-16-000248 | 005-35587 | 162042062 | 34 | 14756 | |||
| 2016-12-08 | 8-K | FORM 8-K | 8.01 | 0001144204-16-138574 | 001-36435 | 162041585 | 34 | 18542 | ||
| 2016-11-29 | 4 | FORM 4 | 0001140361-16-088016 | 12663 | ||||||
| 2016-11-29 | SC 13D/A | enznsch13damd9112816.htm | 0000928464-16-000246 | 005-35587 | 162021248 | 34 | 122786 | |||
| 2016-11-14 | 8-K | FORM 8-K | 8.01 | 0001144204-16-134444 | 001-36435 | 161996918 | 34 | 14359 | ||
| 2016-11-10 | 10-Q | FORM 10-Q | 0001144204-16-133295 | 001-36435 | 161988242 | 34 | 1468017 | 1 | ||
| 2016-10-26 | 8-K | FORM 8-K | 8.01 | 0001144204-16-129621 | 001-36435 | 161952929 | 34 | 11927 | ||
| 2016-08-10 | 10-Q | 10-Q | 0001144204-16-118076 | 001-36435 | 161822158 | 34 | 1399998 | 1 | ||
| 2016-08-09 | 8-K | FORM 8-K | 8.01 | 0001144204-16-117736 | 001-36435 | 161818434 | 34 | 13553 | ||
| 2016-07-05 | 8-K | FORM 8-K | 5.07,8.01 | 0001144204-16-111331 | 001-36435 | 161748125 | 34 | 30452 | ||
| 2016-06-10 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-16-000401 | 000-12957 | 34 | 3767 | 1 | |||
| 2016-06-09 | SC 13G/A | enzon.pharmaceutic.txt | 0000215457-16-006294 | 005-35587 | 161705605 | 34 | 12372 | |||
| 2016-05-16 | 8-K | FORM 8-K | 3.01 | 0001144204-16-102656 | 001-36435 | 161654360 | 34 | 16394 | ||
| 2016-05-13 | DEFA14A | DEFA14A | 0001144204-16-101408 | 001-36435 | 161645781 | 34 | 578843 | |||
| 2016-05-13 | DEF 14A | DEF 14A | 0001144204-16-101406 | 001-36435 | 161645774 | 34 | 863317 | |||
| 2016-05-09 | 10-Q | 10-Q | 0001144204-16-099969 | 001-36435 | 161632492 | 34 | 1314763 | 1 | ||
| 2016-04-28 | 10-K/A | FORM 10-K/A | 0001144204-16-097169 | 001-36435 | 161600909 | 34 | 184504 | |||
| 2016-04-05 | 3 | OWNERSHIP DOCUMENT | 0001144204-16-092800 | 4890 | ||||||
| 2016-03-21 | 10-K | FORM 10-K | 0001144204-16-089172 | 001-36435 | 161518891 | 34 | 3739219 | 1 | ||
| 2016-03-21 | 8-K | FORM 8-K | 5.02,8.01 | 0001144204-16-089169 | 001-36435 | 161518847 | 34 | 19235 | ||
| 2016-02-23 | 8-K | FORM 8-K | 8.01 | 0001144204-16-083875 | 001-36435 | 161449043 | 34 | 17660 | ||
| 2016-02-12 | SC 13G/A | enzon13ga2.htm | 0000935836-16-000729 | 005-35587 | 161417240 | 34 | 46640 | |||
| 2016-02-12 | SC 13G | ENZON PHARMACEUTICALS, INC. | 0001037389-16-000156 | 005-35587 | 161413072 | 34 | 13598 | |||
| 2016-02-09 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001144204-16-080081 | 001-36435 | 161401108 | 34 | 51698 | ||
| 2016-02-09 | DEFA14A | FORM 8-K | 0001144204-16-080082 | 001-36435 | 161401087 | 34 | 51556 | |||
| 2016-01-26 | SC 13G/A | enzon.pharmaceutic.2015.txt | 0000215457-16-002745 | 005-35587 | 161360975 | 34 | 13273 | |||
| 2015-12-07 | 8-K | FORM 8-K | 8.01 | 0001144204-15-069647 | 001-36435 | 151272836 | 34 | 11300 | ||
| 2015-12-03 | 8-K | 8-K | 8.01 | 0001144204-15-069086 | 001-36435 | 151266184 | 34 | 11879 | ||
| 2015-11-12 | 8-K | CURRENT REPORT | 3.01 | 0001144204-15-064280 | 001-36435 | 151220983 | 34 | 14889 | ||
| 2015-11-06 | 10-Q | FORM 10-Q | 0001144204-15-063360 | 001-36435 | 151209986 | 34 | 1666996 | 1 | ||
| 2015-09-15 | 8-K | 8-K | 1.01 | 0001144204-15-055075 | 001-36435 | 151108343 | 34 | 14904 | ||
| 2015-08-07 | 10-Q | 10-Q | 0001144204-15-047327 | 001-36435 | 151037598 | 34 | 1709518 | 1 | ||
| 2015-07-08 | 8-K | FORM 8-K | 8.01 | 0001144204-15-041474 | 001-36435 | 15977755 | 34 | 14335 | ||
| 2015-07-02 | 8-K | FORM 8-K | 5.07,8.01 | 0001144204-15-040856 | 001-36435 | 15969977 | 34 | 29894 | ||
| 2015-05-19 | ARS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-15-010062 | 001-36435 | 15007475 | 34 | 1684 | |||
| 2015-05-15 | DEFA14A | DEFA14A | 0001144204-15-031663 | 001-36435 | 15870064 | 34 | 33466 | |||
| 2015-05-15 | DEF 14A | DEF 14A | 0001144204-15-031658 | 001-36435 | 15870024 | 34 | 862886 | |||
| 2015-05-13 | 10-Q | FORM 10-Q | 0001144204-15-029931 | 001-36435 | 15856608 | 34 | 1910731 | 1 | ||
| 2015-04-28 | PRE 14A | FORM PRE 14A | 0001144204-15-025623 | 001-36435 | 15799648 | 34 | 862956 | |||
| 2015-04-24 | 10-K/A | FORM 10-K/A | 0001144204-15-025025 | 001-36435 | 15792616 | 34 | 203539 | |||
| 2015-03-05 | 10-K | 10-K | 0001144204-15-014238 | 001-36435 | 15677594 | 34 | 6061650 | 1 | ||
| 2015-02-06 | SC 13G/A | enzon13ga.htm | 0000935836-15-000091 | 005-35587 | 15581348 | 34 | 45329 | |||
| 2015-01-22 | SC 13G/A | enzon.pharmaceuticals.i.txt | 0001086364-15-000471 | 005-35587 | 15541385 | 34 | 13193 | |||
| 2014-12-10 | 8-K | 8-K | 8.01 | 0001144204-14-073174 | 001-36435 | 141278300 | 34 | 14618 | ||
| 2014-12-05 | 8-K | FORM 8-K | 8.01 | 0001144204-14-072592 | 001-36435 | 141269917 | 34 | 14083 | ||
| 2014-11-28 | 4 | FORM 4 | 0001140361-14-043674 | 29406 | ||||||
| 2014-11-06 | 10-Q | 10-Q | 0001144204-14-065728 | 001-36435 | 141201538 | 34 | 2686009 | 1 | ||
| 2014-08-08 | 10-Q | 10-Q | 0001144204-14-048065 | 001-36435 | 141027528 | 34 | 2618868 | 1 | ||
| 2014-07-16 | 8-K | CURRENT REPORT | 8.01 | 0001144204-14-043230 | 001-36435 | 14976804 | 34 | 14379 | ||
| 2014-06-12 | 8-K | FORM 8-K | 3.01 | 0001144204-14-037136 | 001-36435 | 14905968 | 34 | 16227 | ||
| 2014-05-30 | 8-K | 8-K | 5.07,8.01 | 0001144204-14-034657 | 001-36435 | 14880743 | 34 | 24647 | ||
| 2014-05-19 | 8-K | 8-K | 8.01 | 0001144204-14-032110 | 001-36435 | 14855156 | 34 | 14980 | ||
| 2014-05-19 | DEFA14A | 8-K | 0001144204-14-032112 | 001-36435 | 14855139 | 34 | 14953 | |||
| 2014-05-09 | 8-K | 8-K | 3.01 | 0001144204-14-029085 | 001-36435 | 14829612 | 34 | 13225 | ||
| 2014-05-09 | 10-Q | 10-Q | 0001144204-14-029062 | 001-36435 | 14829115 | 34 | 2385649 | 1 | ||
| 2014-05-01 | 8-A12B | 8-A12B | 0001144204-14-026849 | 001-36435 | 14805240 | 34 | 31493 | |||
| 2014-05-01 | 8-K | FORM 8-K | 1.01,3.03,5.03,8.01,9.01 | 0001144204-14-026841 | 000-12957 | 14805127 | 34 | 460825 | ||
| 2014-04-18 | ARS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-14-009150 | 001-36435 | 14006744 | 34 | 1684 | |||
| 2014-04-16 | DEFA14A | DEFA14A | 0001144204-14-022909 | 000-12957 | 14766535 | 34 | 605907 | |||
| 2014-04-16 | DEF 14A | DEF 14A | 0001144204-14-022906 | 000-12957 | 14766534 | 34 | 656864 | |||
| 2014-04-09 | SC 13G/A | ENZN13GAMEND6 | 0001061768-14-000026 | 005-35587 | 14753897 | 34 | 132747 | |||
| 2014-03-25 | 8-K | 8-K | 3.01 | 0001144204-14-017632 | 000-12957 | 14716310 | 34 | 16076 | ||
| 2014-03-14 | 10-K | 10-K | 0001144204-14-015753 | 000-12957 | 14694708 | 34 | 10188622 | 1 | ||
| 2014-03-13 | SC 13G | SC 13G | 0001193125-14-096618 | 005-35587 | 14689566 | 34 | 82455 | |||
| 2014-02-12 | SC 13G/A | enzonpharmaceuticalsinc.htm | 0000932471-14-003866 | 005-35587 | 14597003 | 34 | 52117 | |||
| 2014-01-10 | SC 13G/A | enzon.pharmaceuticals.inc..txt | 0001086364-14-000047 | 005-35587 | 14519653 | 34 | 13270 | |||
| 2014-01-09 | SC 13G/A | ENZN13GAMEND5.PDML | 0001061768-14-000004 | 005-35587 | 14518911 | 34 | 159646 | |||
| 2013-12-16 | 8-K | CURRENT REPORT | 5.02,8.01 | 0001144204-13-067350 | 000-12957 | 131277944 | 34 | 21481 | ||
| 2013-12-13 | 3 | OWNERSHIP DOCUMENT | 0001144204-13-067286 | 3149 | ||||||
| 2013-12-05 | 8-K | 8-K | 8.01 | 0001144204-13-065845 | 000-12957 | 131260205 | 34 | 11714 | ||
| 2013-11-21 | 8-K | 8-K | 5.07,8.01 | 0001144204-13-063553 | 000-12957 | 131235950 | 34 | 26599 | ||
| 2013-11-12 | 10-Q | FORM 10-Q | 0001144204-13-060539 | 000-12957 | 131210594 | 34 | 4663958 | 1 | ||
| 2013-10-22 | 8-K | 8-K | 5.02,8.01 | 0001144204-13-056282 | 000-12957 | 131163914 | 34 | 17739 | ||
| 2013-10-15 | ARS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-13-015893 | 000-12957 | 13003521 | 34 | 1684 | |||
| 2013-10-15 | 8-K | 8-K | 8.01 | 0001144204-13-055265 | 000-12957 | 131152345 | 34 | 13199 | ||
| 2013-10-11 | DEFA14A | DEFA14A | 0001144204-13-054854 | 000-12957 | 131147004 | 34 | 604270 | |||
| 2013-10-11 | DEF 14A | DEF 14A | 0001144204-13-054852 | 000-12957 | 131147001 | 34 | 1078891 | |||
| 2013-10-09 | 3 | FORM 3 | 0001140361-13-038299 | 3387 | ||||||
| 2013-10-09 | SC 13D/A | enznsch13damd8100913.htm | 0000928464-13-000257 | 005-35587 | 131143675 | 34 | 35355 | |||
| 2013-10-09 | 8-K | 8-K | 5.02 | 0001144204-13-054571 | 000-12957 | 131143667 | 34 | 20204 | ||
| 2013-10-07 | 3 | OWNERSHIP DOCUMENT | 0001144204-13-054317 | 3296 | ||||||
| 2013-10-07 | 3 | OWNERSHIP DOCUMENT | 0001144204-13-054315 | 3262 | ||||||
| 2013-10-01 | 8-K | 8-K | 1.01,5.02,8.01 | 0001144204-13-053370 | 000-12957 | 131127299 | 34 | 27107 | ||
| 2013-09-19 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-051642 | 7326 | ||||||
| 2013-08-12 | 8-K | 8-K | 4.01,9.01 | 0001144204-13-044762 | 000-12957 | 131030327 | 34 | 28197 | ||
| 2013-08-09 | 8-K | 8-K | 5.02 | 0001144204-13-044471 | 000-12957 | 131027189 | 34 | 16238 | ||
| 2013-08-06 | 10-Q | 10-Q | 0001144204-13-043344 | 000-12957 | 131014299 | 34 | 5263669 | 1 | ||
| 2013-07-25 | 8-K | 8-K | 5.02 | 0001144204-13-041192 | 000-12957 | 13986828 | 34 | 17962 | ||
| 2013-06-14 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001193125-13-259858 | 005-35587 | 13915140 | 34 | 88949 | |||
| 2013-05-10 | 10-Q | FORM 10-Q | 0001144204-13-027985 | 000-12957 | 13834028 | 34 | 2784762 | 1 | ||
| 2013-05-06 | 8-K | 8-K | 8.01 | 0001144204-13-026576 | 000-12957 | 13817035 | 34 | 16912 | ||
| 2013-04-30 | 10-K/A | FORM 10-K/A | 0001144204-13-025224 | 000-12957 | 13798602 | 34 | 600414 | |||
| 2013-04-24 | 8-K | 8-K | 8.01,9.01 | 0001144204-13-023447 | 000-12957 | 13777313 | 34 | 33044 | ||
| 2013-03-26 | 8-K | FORM 8-K | 2.05 | 0001144204-13-017546 | 000-12957 | 13717162 | 34 | 13536 | ||
| 2013-03-18 | 8-K | FORM 8-K | 2.02,9.01 | 0001144204-13-015913 | 000-12957 | 13698867 | 34 | 119809 | ||
| 2013-03-18 | 10-K | 10-K | 0001144204-13-015878 | 000-12957 | 13698341 | 34 | 7237532 | 1 | ||
| 2013-02-28 | 8-K | 8-K | 5.02,9.01 | 0001144204-13-012084 | 000-12957 | 13652857 | 34 | 64053 | ||
| 2013-02-21 | 8-K | 8-K | 8.01 | 0001144204-13-010540 | 000-12957 | 13631258 | 34 | 14110 | ||
| 2013-02-13 | SC 13G/A | ENZN13GAMEND4 | 0001061768-13-000014 | 005-35587 | 13603513 | 34 | 157726 | |||
| 2013-02-12 | 8-K | 8-K | 5.02,5.03,9.01 | 0001144204-13-007817 | 000-12957 | 13597665 | 34 | 91441 | ||
| 2013-02-12 | SC 13G | enzonphamaceuticalsinc.htm | 0000932471-13-004167 | 005-35587 | 13597024 | 34 | 52085 | |||
| 2013-02-11 | SC 13G/A | enzon.pharmaceuticals.inc..txt | 0001086364-13-003548 | 005-35587 | 13588464 | 34 | 13419 | |||
| 2013-02-06 | SC 13G/A | enzon.pharmaceuticals.inc..txt | 0001086364-13-002727 | 005-35587 | 13576404 | 34 | 13442 | |||
| 2013-01-31 | SC 13G/A | enzon13ga3123112.htm | 0001033427-13-000012 | 005-35587 | 13560978 | 34 | 94945 | |||
| 2013-01-25 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-004109 | 6316 | ||||||
| 2013-01-25 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-004105 | 6221 | ||||||
| 2013-01-25 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-004103 | 6229 | ||||||
| 2013-01-04 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-000678 | 5888 | ||||||
| 2013-01-04 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-000676 | 5887 | ||||||
| 2013-01-04 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-000673 | 5750 | ||||||
| 2013-01-04 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-000671 | 5890 | ||||||
| 2013-01-04 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-000668 | 5858 | ||||||
| 2013-01-04 | 4 | OWNERSHIP DOCUMENT | 0001144204-13-000666 | 5990 | ||||||
| 2013-01-02 | SC 13G | SCHEDULE 13G - ENZON PHARMACEUTICALS, INC. | 0000906344-13-000004 | 005-35587 | 13502464 | 34 | 118730 | |||
| 2012-12-20 | 8-K | 8-K | 2.05,8.01,9.01 | 0001144204-12-069009 | 000-12957 | 121277976 | 34 | 46526 | ||
| 2012-11-30 | 8-K | 8-K | 8.01,9.01 | 0001144204-12-065661 | 000-12957 | 121233178 | 34 | 24885 | ||
| 2012-11-28 | SC 13D/A | enznsch13damd7112712.htm | 0000928464-12-000301 | 005-35587 | 121227687 | 34 | 35324 | |||
| 2012-11-13 | SC 13D/A | enznsch13damd6110912.htm | 0000928464-12-000282 | 005-35587 | 121195074 | 34 | 183766 | |||
| 2012-11-09 | 10-Q | FORM 10-Q | 0001144204-12-060778 | 000-12957 | 121193061 | 34 | 3563794 | 1 | ||
| 2012-11-08 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-060400 | 8409 | ||||||
| 2012-10-31 | 8-K | 8-K | 2.02,9.01 | 0001144204-12-058564 | 000-12957 | 121169977 | 34 | 80750 | ||
| 2012-10-12 | UPLOAD | filename1.pdf | 0000000000-12-056588 | 34692 | ||||||
| 2012-09-20 | CORRESP | filename1.htm | 0001144204-12-052206 | 40736 | ||||||
| 2012-09-07 | UPLOAD | filename1.pdf | 0000000000-12-048852 | 141944 | ||||||
| 2012-09-06 | SC 13G/A | enzn13ga2083112.htm | 0001033427-12-000032 | 005-35587 | 121076087 | 34 | 97534 | |||
| 2012-08-21 | 10-Q/A | 10-Q/A | 0001144204-12-047370 | 000-12957 | 121047540 | 34 | 2309032 | 1 | ||
| 2012-08-15 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-046171 | 4789 | ||||||
| 2012-08-13 | CORRESP | filename1.htm | 0001144204-12-044890 | 79016 | ||||||
| 2012-08-13 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-044710 | 4796 | ||||||
| 2012-08-03 | 10-Q | FORM 10-Q | 0001144204-12-042768 | 000-12957 | 121006669 | 34 | 364746 | |||
| 2012-08-01 | 8-K | 8-K | 2.02,9.01 | 0001144204-12-042169 | 000-12957 | 12998602 | 34 | 71755 | ||
| 2012-07-30 | UPLOAD | filename1.pdf | 0000000000-12-040592 | 166264 | ||||||
| 2012-07-03 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-038081 | 5470 | ||||||
| 2012-07-03 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-038077 | 5332 | ||||||
| 2012-07-03 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-038074 | 5441 | ||||||
| 2012-07-03 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-038070 | 5469 | ||||||
| 2012-07-03 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-038067 | 5472 | ||||||
| 2012-07-03 | 4 | OWNERSHIP DOCUMENT | 0001144204-12-038064 | 5572 | ||||||
| 2012-06-26 | 8-K/A | c70100_8ka.htm | 5.02 | 0000930413-12-003733 | 000-12957 | 12927940 | 34 | 10223 | ||
| 2012-06-21 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-003658 | 11523 | ||||||
| 2012-06-06 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-003456 | 4856 | ||||||
| 2012-06-06 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-003455 | 5359 | ||||||
| 2012-05-22 | 8-K | c69791_8k.htm | 5.02,5.07 | 0000930413-12-003232 | 000-12957 | 12862296 | 34 | 25250 | ||
| 2012-05-07 | 8-K | c69620_8k.htm | 8.01,9.01 | 0000930413-12-002864 | 000-12957 | 12816841 | 34 | 34280 | ||
| 2012-05-02 | 10-Q | c69479_10-q.htm | 0000930413-12-002742 | 000-12957 | 12805489 | 34 | 1981517 | 1 | ||
| 2012-05-02 | 8-K | c69509_8-k.htm | 2.02,9.01 | 0000930413-12-002722 | 000-12957 | 12803150 | 34 | 81962 | ||
| 2012-04-10 | SC 13G/A | ENZON PHARMACEUTICALS SC 13GA 3-31-2012 | 0001140361-12-019887 | 005-35587 | 12751546 | 34 | 22998 | |||
| 2012-04-06 | ARS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-12-008585 | 000-12957 | 12026676 | 34 | 1684 | |||
| 2012-04-06 | DEFA14A | c69170_defa14a.htm | 0000930413-12-002094 | 000-12957 | 12747023 | 34 | 25265 | |||
| 2012-04-06 | DEF 14A | c68795_def14a.htm | 0000930413-12-002093 | 000-12957 | 12747011 | 34 | 652719 | |||
| 2012-03-29 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-001901 | 5556 | ||||||
| 2012-03-16 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-001600 | 5322 | ||||||
| 2012-03-12 | 10-K | c68781_10-k.htm | 0000930413-12-001483 | 000-12957 | 12683808 | 34 | 5286158 | 1 | ||
| 2012-03-12 | 8-K | c68804_8-k.htm | 2.02,9.01 | 0000930413-12-001477 | 000-12957 | 12682517 | 34 | 121942 | ||
| 2012-02-29 | 4 | FORM 4 | 0001140361-12-011943 | 8271 | ||||||
| 2012-02-29 | 3 | FORM 3 | 0001140361-12-011941 | 3371 | ||||||
| 2012-02-28 | 8-K | c68733_8k.htm | 5.02 | 0000930413-12-001168 | 000-12957 | 12648777 | 34 | 11520 | ||
| 2012-02-28 | 3/A | FORM 3/A | 0001140361-12-011502 | 10554 | ||||||
| 2012-02-28 | SC 13D/A | enznsch13damd5022412.txt | 0000928475-12-000028 | 005-35587 | 12648380 | 34 | 27005 | |||
| 2012-02-14 | SC 13G/A | ENZON PHARMACEUTICALS SC 13GA 12-31-2011 | 0001140361-12-007948 | 005-35587 | 12607888 | 34 | 23235 | |||
| 2012-02-14 | SC 13G/A | ENZON PHARMACEUTICALS, INC. | 0000902664-12-000344 | 005-35587 | 12604343 | 34 | 113842 | |||
| 2012-02-13 | 8-K | c68568_8-k.htm | 8.01 | 0000930413-12-000690 | 000-12957 | 12595509 | 34 | 9552 | ||
| 2012-02-10 | SC 13G/A | ENZN13GAMEND3 | 0001061768-12-000014 | 005-35587 | 12592789 | 34 | 160642 | |||
| 2012-02-09 | SC 13G/A | enzon.pharmaceuticals.inc..txt | 0001086364-12-000355 | 005-35587 | 12584388 | 34 | 13431 | |||
| 2012-02-06 | SC 13G/A | enzon13ga1123111.htm | 0001033427-12-000010 | 005-35587 | 12572182 | 34 | 96966 | |||
| 2012-01-19 | 4/A | OWNERSHIP DOCUMENT | 0000930413-12-000231 | 6665 | ||||||
| 2012-01-19 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-000230 | 8323 | ||||||
| 2012-01-19 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-000229 | 9233 | ||||||
| 2012-01-19 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-000228 | 8427 | ||||||
| 2012-01-19 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-000227 | 8325 | ||||||
| 2012-01-19 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-000226 | 7720 | ||||||
| 2012-01-05 | 4 | OWNERSHIP DOCUMENT | 0000930413-12-000048 | 5889 |
One latest value per concept from companyfacts (443 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 14.33M | 2026-11-01 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 4.92M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-04-29 | 0001104659-26-051643 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 42.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 73.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 69.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.35M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 27.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 33,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 | |
| us-gaap | AccruedRentNoncurrent | Accrued Rent, Noncurrent | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 29,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | AccruedRoyaltiesCurrentAndNoncurrent | Accrued Royalties | USD | 324,000 | 2019-12-31 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001104659-20-123067 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 347.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -59.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 267.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | USD | 2.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities | Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | USD | -8.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001410578-25-000177 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 3.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 1.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 25,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 |
| us-gaap | AreaOfLand | Area of Land | acre | 30,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 362,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | Assets | Assets | USD | 427.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 226.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | AssetsHeldForSaleCurrent | Assets Held-for-sale, Current (Deprecated 2014-01-31) | USD | 55,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001144204-14-029062 | |
| us-gaap | AssetsHeldForSalePropertyPlantAndEquipment | Assets Held-for-sale, Property, Plant and Equipment (Deprecated 2014-01-31) | USD | 90,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 119.39M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 119.31M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 38.10M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 25.25M | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-04 | 0000930413-11-006994 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost | Available-for-sale Securities, Debt Maturities, Amortized Cost Basis (Deprecated 2014-01-31) | USD | 119.31M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 119.31M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 119.39M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue | Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | USD | 119.39M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | AvailableForSaleSecuritiesFairValueDisclosure | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | USD | 77.57M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) | USD | 300,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGain | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | USD | 55,000 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedGains | Available-for-sale Securities, Gross Unrealized Gain | USD | 94,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLoss | Available-for-sale Securities, Gross Unrealized Loss | USD | 11,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLosses1 | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | USD | 16,000 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 | |
| us-gaap | BasicEarningsPerShareProForma | Basic Earnings Per Share, Pro Forma | USD/shares | -7.46 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityCashPaid | Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) | USD | 308.00M | 2010-06-30 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityPurchasePrice | Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) | USD | 303.00M | 2010-06-30 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 5.00M | 2010-06-30 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 7.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | Cash | Cash | USD | 38.99M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-07 | 0001144204-15-047327 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 7.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -2.94M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-08 | 0001144204-19-024510 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 7.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -1.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 42.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Investing Activities, Discontinued Operations | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Operating Activities, Discontinued Operations | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | CommitmentsAndContingencies | Commitments and Contingencies | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001104659-20-123067 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 25.53M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | CommonStockDividendsPerShareCashPaid | Common Stock, Dividends, Per Share, Cash Paid | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | CommonStockDividendsPerShareDeclared | Common Stock, Dividends, Per Share, Declared | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 170.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 14.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 14.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 143,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -21.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -22.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 243.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 55,000 | 2013-07-01 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 147.821 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 6.76 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.04 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | DebtInstrumentRepurchasedFaceAmount | Debt Instrument, Repurchased Face Amount | USD | 13.65M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 | |
| us-gaap | DeferredCompensationLiabilityCurrent | Deferred Compensation Liability, Current | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | DeferredCompensationPlanAssets | Deferred Compensation Plan Assets | USD | 2.50M | 2011-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 13,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | 17,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | DeferredFinanceCostsCurrentNet | Debt Issuance Costs, Current, Net | USD | 1.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | DeferredFinanceCostsNoncurrentNet | Debt Issuance Costs, Noncurrent, Net | USD | 1.95M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-03 | 0001104659-26-089804 | |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 17,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 119,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 457,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001104659-20-123067 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 4,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-21 | 0001144204-19-009301 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 29.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | DeferredTaxAssetsInvestments | Deferred Tax Assets, Investments | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 17,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetCurrent | Deferred Tax Assets, Net, Current | USD | 2.20M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001144204-17-057832 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 20.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax | Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 8.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpense | Deferred Tax Assets, Tax Deferred Expense | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 29.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | DeferredTaxLiabilitiesTaxDeferredIncome | Deferred Tax Liabilities, Tax Deferred Income | USD | 800,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | DeferredTaxLiabilitiesUndistributedForeignEarnings | Deferred Tax Liabilities, Undistributed Foreign Earnings | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 787,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 742,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.06 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) | pure | 0.5 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.5 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | Depreciation | Depreciation | USD | 11.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 12.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | DilutedEarningsPerShareProForma | Diluted Earnings Per Share Pro Forma | USD/shares | -7.46 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax | Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | USD | 3.62M | 2010-01-01 | 2010-01-29 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | USD | 176.40M | 2010-04-01 | 2010-06-30 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation | USD | 0 | 2010-01-01 | 2010-01-29 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationRevenue | Disposal Group, Including Discontinued Operation, Revenue | USD | 8.72M | 2010-01-01 | 2010-01-29 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | DividendsCommonStockCash | Dividends, Common Stock, Cash | USD | 5.31M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001104659-19-060500 |
| us-gaap | DividendsCommonStockStock | Dividends, Common Stock, Stock | USD | 1.27M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-20 | 0001410578-24-000245 |
| us-gaap | DividendsPayableAmountPerShare | Dividends Payable, Amount Per Share | USD/shares | 0.5 | 2015-06-30 | 2016 | Q2 | 10-Q | 2016-08-10 | 0001144204-16-118076 | |
| us-gaap | DividendsPayableCurrent | Dividends Payable, Current | USD | 1.27M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001104659-20-123067 | |
| us-gaap | DividendsPreferredStockStock | Dividends, Preferred Stock, Stock | USD | 531,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-10 | 0001410578-24-000735 |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 111,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 | |
| us-gaap | DueToRelatedPartiesCurrentAndNoncurrent | Due to Related Parties | USD | 306,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001104659-20-123067 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.49 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.01 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001104659-21-100764 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.49 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.064 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.781 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.245 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 1 | 2021-01-01 | 2021-12-31 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001104659-19-060500 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -208,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 3.10M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 800,000 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 12.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | 33,000 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactions | Future Minimum Sublease Rentals, Sale Leaseback Transactions | USD | 2.31M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Thereafter | USD | 1.08M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears | Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Four Years | USD | 420,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next Twelve Months | USD | 193,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears | Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Three Years | USD | 356,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears | Future Minimum Sublease Rentals, Sale Leaseback Transactions, within Two Years | USD | 258,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | GainLossOnContractTermination | Gain (Loss) on Contract Termination | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | GainLossOnDispositionOfProperty | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) | USD | -61,000 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-04 | 0000930413-11-006994 |
| us-gaap | GainLossOnRepurchaseOfDebtInstrument | Gain (Loss) on Repurchase of Debt Instrument | USD | 212,000 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 26.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | Goodwill | Goodwill | USD | 3.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | GrossProfit | Gross Profit | USD | 28.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 9.60M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -2.78M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -3.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -17.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -2.78M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -0.06 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.11 | 2012-10-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.11 | 2012-10-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share | USD/shares | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 0 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-04 | 0000930413-11-006994 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 0 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-04 | 0000930413-11-006994 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001104659-25-110410 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 3.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 485,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-23 | 0001104659-21-026712 | |
| us-gaap | IncomeTaxesReceivableNoncurrent | Income Taxes Receivable, Noncurrent | USD | 485,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-23 | 0001104659-21-026712 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | -4.13M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 11.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-21 | 0001144204-19-009301 |
| us-gaap | IncomeTaxReconciliationDispositionOfBusiness | Effective Income Tax Rate Reconciliation, Disposition of Business, Amount | USD | 4.50M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -712,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 831,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-23 | 0001104659-21-026712 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncomeTaxReconciliationRepatriationOfForeignEarnings | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 6,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | IncomeTaxReconciliationTaxExemptIncome | Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-21 | 0001144204-19-009301 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -4.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 29,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 11.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 4.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 15.90M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-02-21 | 0001144204-19-009301 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -381,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 6.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInLongTermReceivablesCurrent | Increase (Decrease) in Long-term Receivables, Current | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 |
| us-gaap | IncreaseDecreaseInOperatingCapital | Increase (Decrease) in Operating Capital | USD | 583,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 328,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 6.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -1.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 23,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | -19,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001104659-25-110410 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -492,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 0 | 2025-04-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001410578-25-001810 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 0 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-10 | 0001144204-18-043614 |
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | -8.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | InterestOnConvertibleDebtNetOfTax | Interest on Convertible Debt, Net of Tax | USD | 0 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.30M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 7.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | InventoryAdjustments | Inventory Adjustments | USD | 4.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 30.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 100.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 29.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 40.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 2.50M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 708,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001144204-19-038191 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 1.09M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | Liabilities | Liabilities | USD | 4.80M | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 427.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 210.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | LiabilityForUncertainTaxPositionsNoncurrent | Liability for Uncertainty in Income Taxes, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 135.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 135.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 84.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 49.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 74.93M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-03 | 0001104659-26-089804 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 115.85M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 24.08M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001104659-20-022802 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | MarketableSecuritiesGainLoss | Marketable Securities, Gain (Loss) | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 900,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | -1.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 115.20M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 49.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -6.63M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -23.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -27.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 3.57M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-10 | 0001144204-17-042058 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -18.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | -141,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | 23.00M | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -18.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -18.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NoncurrentAssets | Long-Lived Assets | USD | 180.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | NotesPayable | Notes Payable | USD | 115.85M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | NotesPayableFairValueDisclosure | Notes Payable, Fair Value Disclosure | USD | 117.08M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 4 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 4 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 5.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -9.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 729 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-29 | 0001104659-20-087796 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 4.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 15.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 17.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 4.92M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 703,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals | USD | 2.49M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 394,000 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 774,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 742,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 703,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 2.00M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivable | Operating Leases, Future Minimum Payments Receivable | USD | 400,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | OperatingLeasesIncomeStatementSubleaseRevenue | Operating Leases, Income Statement, Sublease Revenue | USD | 42,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 400,000 | 2010-07-01 | 2010-09-30 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 101.90M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001410578-25-001164 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 9,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 48.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | OtherAssetsMiscellaneousCurrent | Other Assets, Miscellaneous, Current | USD | 4.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 7.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) | USD | -742,000 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-12 | 0000930413-12-001483 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | OtherComprehensiveIncomeLossBeforeTax | Other Comprehensive Income (Loss), before Tax | USD | -3.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -3.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -3.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | USD | -141,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax | USD | 502,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) | USD | -281,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 0 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | -71,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-04 | 0001104659-26-054911 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | USD | 237,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 1.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | OtherInterestAndDividendIncome | Other Interest and Dividend Income | USD | 1.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | OtherMarketableSecuritiesCurrent | Other Marketable Securities, Current (Deprecated 2018-01-31) | USD | 2.50M | 2011-12-31 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 646,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 780,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 3.50M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 | |
| us-gaap | OtherRestructuringCosts | Other Restructuring Costs | USD | 775,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | OtherSalesRevenueNet | Other Revenue, Net (Deprecated 2018-01-31) | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent | Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, before Tax, Portion Attributable to Parent | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 867,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | PaymentsOfDividendsCommonStock | Payments of Ordinary Dividends, Common Stock | USD | 1.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 2.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | PaymentsToAcquireProductiveAssets | Payments to Acquire Productive Assets | USD | 23.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent | Liability, Pension and Other Postretirement and Postemployment Benefits, Current | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 | |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 2.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 2.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001410578-22-002040 | |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 15.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 647,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-03 | 0001104659-26-089804 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | -115.85M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001144204-13-043344 |
| us-gaap | ProceedsFromRoyaltiesReceived | Proceeds from Royalties Received | USD | 115,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-23 | 0001104659-21-026712 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | ProceedsFromSaleOfIntangibleAssets | Proceeds from Sale of Intangible Assets | USD | 700,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001410578-25-000177 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 0 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -18.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | ProFormaWeightedAverageSharesOutstandingDiluted | Pro Forma Weighted Average Shares Outstanding, Diluted | shares | 742,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 503.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 155.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 4.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 1.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 50.50M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated | Restructuring and Related Cost, Expected Number of Positions Eliminated | Employees | 4 | 2013-07-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | employee | 210 | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 714,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 153,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | RestructuringReserveAccrualAdjustment | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | USD | 268,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 503,000 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 | |
| us-gaap | RestructuringReserveNoncurrent | Restructuring Reserve, Noncurrent | USD | 291,000 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001144204-14-065728 | |
| us-gaap | RestructuringReserveSettledWithCash | Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | USD | -3.40M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-09 | 0001144204-12-060778 |
| us-gaap | RetainageDeposit | Retainage Deposit | USD | 259 | 2019-08-31 | 2020 | Q2 | 10-Q | 2020-07-29 | 0001104659-20-087796 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -30.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 271.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 27.00M | 2010-01-01 | 2010-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | Revenues | Revenues | USD | 26,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | RoyaltyIncomeNonoperating | Royalty Income, Nonoperating | USD | 54,000 | 2018-07-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001144204-18-057974 |
| us-gaap | RoyaltyRevenue | Royalty Revenue (Deprecated 2018-01-31) | USD | 15,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001144204-18-027186 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 15,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001144204-18-027186 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 259 | 2019-08-31 | 2020 | Q2 | 10-Q | 2020-07-29 | 0001104659-20-087796 | |
| us-gaap | SegmentExpenditureAdditionToLongLivedAssets | SegmentExpenditureAdditionToLongLivedAssets | USD | 23.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | SellingAndMarketingExpense | Selling and Marketing Expense | USD | 7.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 35.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | SeveranceCosts | Severance Costs (Deprecated 2013-01-31) | USD | 900,000 | 2012-01-01 | 2012-12-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001144204-13-027985 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 52,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-05 | 0001410578-21-000030 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 45,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | -100,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.55 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.343 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.008 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 17,339 | 2012-09-30 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 1.31 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 25,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 221,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-19 | 0001104659-20-022802 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 0 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-05 | 0001410578-23-000888 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 1.31 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 1.31 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001410578-22-000226 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 1.31 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-16 | 0001410578-23-000136 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 3.03 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | SharePrice | Share Price | USD/shares | 1 | 2016-08-09 | 2016 | Q3 | 10-Q | 2016-11-10 | 0001144204-16-133295 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.58 | 2026-01-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 135.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 41.08M | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-05 | 0000930413-11-005153 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 178.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 177.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 1.27M | 2026-01-01 | 2026-01-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001410578-22-003068 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 39.98M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 114.75M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 12,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-05 | 0001144204-15-014238 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 15.00M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.92M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-12 | 0000930413-12-001483 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationGross | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | USD | 6,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-24 | 0001144204-17-016511 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 5.45M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-14 | 0001144204-14-015753 |
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-21 | 0001144204-18-016199 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodShares | Stock Repurchased and Retired During Period, Shares | shares | 16.17M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 153.40M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | StockRepurchaseProgramAuthorizedAmount | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) | USD | 200.00M | 2010-12-01 | 2010-12-21 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001144204-14-029062 |
| us-gaap | StockRepurchaseProgramAuthorizedAmount1 | Stock Repurchase Program, Authorized Amount | USD | 200.00M | 2010-12-21 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 | |
| us-gaap | Supplies | Prepaid Supplies | USD | 19.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 362,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 14.80M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-23 | 0001104659-21-026712 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 433,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TemporaryEquityLiquidationPreferencePerShare | Temporary Equity, Liquidation Preference Per Share | USD/shares | 1,129 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 3.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 384 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 384 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | TemporaryEquityStockIssuedDuringPeriodValueNewIssues | Temporary Equity, Stock Issued During Period, Value, New Issues | USD | 40.00M | 2020-10-01 | 2020-10-31 | 2024 | Q1 | 10-Q | 2024-05-10 | 0001410578-24-000735 |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 0 | 2004-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 | |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 200,000 | 2012-12-31 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 | |
| us-gaap | ValuationAllowanceAmount | Valuation Allowance, Amount (Deprecated 2013-01-31) | USD | 102.10M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001144204-13-015878 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 11.11M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-21 | 0001144204-16-089172 |
| us-gaap | WeightedAverageBasicSharesOutstandingProForma | Weighted Average Basic Shares Outstanding, Pro Forma | shares | 742,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-02 | 0001104659-26-022313 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 11,631 | 2025-01-01 | 2025-12-31 | 2026 | Q2 | 10-Q | 2026-08-03 | 0001104659-26-089804 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 12.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 74,215 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-04 | 0001104659-21-060966 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 12.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001104659-26-121529 |
| us-gaap | WriteOffOfDeferredDebtIssuanceCost | Write off of Deferred Debt Issuance Cost | USD | 62,000 | 2012-01-01 | 2012-12-31 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001144204-13-060539 |